Current information on Knowledge and Technology Transfer can be found here.

OMEICOS Therapeutics closes €17 Mio. Series C Financing to OMT-28 towards Pivotal Trials in Atrial Fibrillation

OMEICOS Therapeutics, a spin-off from Max Delbruck Center for Molecular Medicine and former Helmholtz Enterprise project, successfully closed series C financing. The investment provided by new lead investor Forbion together with existing investors Vesalius Biocapital II S.A. SICAR Remiges BioPharma Fund, SMS group GmbH, KFW Group, VC Fonds Technologie Berlin, High-Tech-Gründerfonds II GmbH & Co. KG and The Falck Revocable Trust. This initiates the pivotal Trials (phase-II study) for the substance OMT-28 for a novel and safe rhythm stabilizer for patients with atrial fibrillation.

Continue reading on High-Tech-Gruenderfonds page


SenseUp is the winner of the EARTO Innovation Awards 2018 in the category "Impact Expected"

The spin-off SenseUp of Forschungszentrum Jülich and the former Helmholtz Enterprise project has been awarded by the EARTO Innovation Awards 2018 (European Association of  Research and Technology Organisation) as the best in the category "Impact Expected". The innovative sensor technology accelerates the microorganism screening process by a factor of a million. The developed sensor technology detects the most productive ones among millions of microorganisms for the production of nutrients and medical substances. And enable a more efficient manufacturing process in the field of biotechnology.


Memetis GmbH receives a funding of a seven-figure amount for their innovative actuator technology in an ultra-compact design

The spin-off memetis GmbH of the Karlsruher Institut für Technologie (KIT), a former Helmholtz Enterprise project by the name of SMActuators, successfully completed its first funding round. The leading investors are High-Tech Gründerfonds (HTGF) and KIT. The funding supports memetis’ business development in particular the establishment of the relatively unknown technology and various actuator applications in the market as well as expanding its own development and production capabilities. Read more

Successful VC financing of the Helmholtz Enterprise Alumni i3 Membrane

30.11.2016 - Four investors are financing continued growth by i3 Membrane GmbH. High-Tech Gründerfonds (HTGF) in Bonn, Innovationsstarter Fonds in Hamburg, Mittelständische Beteiligungsgesellschaft Sachsen mbH (MBG) in Dresden and a private US investor are investing a 7-digit Euro sum in further developing and launching new filters and separation technologies. Ultra-thin metal coatings on conventional membranes can be charged with electric current to capture charged nanoparticles such as viruses and cytotoxins – and can be controlled using a computer. Making biotechnological processes more efficient and simple while filters become smaller and more environmentally friendly. Read the press release of HTGF.

Helmholtz-Enterprise: Spin-Offs from the HZDR and their experiences with grant schemes “Helmholtz-Enterprise” and “EXIST”

Together with the HZDR, we have prepared an information session for potential founders:

“High-tech Spin-Offs: Inspiration, Opportunities and How-To-Do's”
on November 24th, 10:30 am - 15:30 pm
at the HZDR, building 114 (seminar room) or building 801 (room 142)

We will inform you about the possibilities to effectively transfer your research results and your knowledge into new fields of applicationan through an academic spin-off.

The program consists of the following contributions:

  • Presentation of the spin-off promotion "Helmholtz-Enterprise"
  • Presentation of the spin-off promotion "EXIST" and the support by dresden|exists
  • Review: HEF promotion and spin-off of the HZDR
  • Review: EXIST promotion and spin-off of the HZDR
  • Assistance in the spin-off by HZDR Innovation GmbH
  • Possibly panel discussion

All interested employees of the Helmholtz Centres are welcome. The presentations will be given in German, nevertheless questions can be answered in English.
Please register in advance at Mr. Sebastian Löbelt-Friedrich (sebastian.loebelt-friedrich(at)

Captain T Cell: Start-up from the MDC wins OneStart competition in London

21.06.2016 - For the first time, a German team has won the world’s biggest life-science start-up competition. Captain T Cell, founded by Dr Felix Lorenz and several colleagues at the Max Delbrück Center for Molecular Medicine (MDC), beat 400 international start-ups to win prize money totalling GBP 100,000. The team will use the funds to further develop their innovative approach to cancer immunotherapy. Their goal is to create a platform for the production of personalized, cancer-specific T cell receptors. With the help of these receptors, the body’s own T cells, so called ‘killer cells’, are able to find and specifically destroy cancer cells in the patient’s body. (READ MORE)

Helmholtz Association among the world's most innovative research institutions

March, 8th 2016 - The Reuters news agency rates the Helmholtz Association in the Top 25 Global Innovators. The rating takes into account all transfer activities of public research institutions worldwide in the past eight years. The Helmholtz Association archives the 11th place doing the most to advance science and technology.

News article

Helmholtz validation funding extended, facilitating further projects

December 16th, 2015 - Developing pioneering technologies and making them attractive for industry often requires a great deal of patience and perseverance. The Helmholtz Validation Fund (HVF) is therefore providing support to a number of particularly promising projects carried out by research teams in the Helmholtz Association. A total of 21 projects were selected for the first funding period from 2011 to 2015. Following a successful evaluation process, the programme will now continue from 2016 to 2020. The first three projects to be funded in the new programme phase were selected this December by the experts on the decision-making board. These projects could pave the way to discovering new and better ways of diagnosing and treating diseases such as cancer, osteoporosis and Alzheimer’s.

Press release

Magna-Helmholtz-Research Day in Bad Homburg

14.11.2014: The Magna-Helmholtz Research Days brought together 65 experts from the Magna industry and the Helmholtz Association on November 6-7 2014. Magna is a leading global automotive supplier with 130.000 employees, 317 manufacturing operations and 83 product development, engineering and sales centres in 29 countries. On the first day, the Magna Power Train plant in Bad Homburg was visited, being a premier supplier for the global automotive industry with full capabilities in powertrain design, development, testing and manufacturing. On the second day, 23 Helmholtz experts from AWI, FZJ, HZG, KIT and DLR presented and discussed topics of mutual interest, such as Leight Weight Technologies and Multimaterial Joining, Powertrain Components Materials and Design, Connectivity and Propulsion, as well as Energy Storage 2030

In the light of the German Energy Turnaround (Energiewende), Energy Storage is a growing research programme at Helmholtz, developing the technologies required to shape the Energy System 2050. With the Energy Lab 2.0 Project, the Helmholtz centre KIT concentrates on the design, assessment and demonstration of a new interconnected energy grid of electricity, gas, hydrogen, fuel, heat and information

Source: KIT (

Helmholtz supports research projects on their way to application

October 27th, 2014 - Developing pioneering technologies and making them attractive for industry: the Helmholtz Association is channelling more than €20 million from its Initiative and Networking Fund into helping scientists quickly move their projects from research to application. Fifteen projects have been funded since the launch in 2011, and now independent assessors have recommended that a further three should receive support: a system that can produce high-precision maps, an effective process for generating heat in solar tower power plants, and an active pharmaceutical ingredient that could be used in the treatment of ischemia in the future. The Helmholtz Association believes these three developments have huge potential for achieving successful commercial application and making a significant contribution to society.

Press release

Helmholtz Association facilitates new spin-offs

September 1st, 2014 - The Helmholtz Association is providing up to €130,000 of funding for each of four new spin-off proposals by Helmholtz researchers. This brings the total number of Helmholtz centre spin-offs funded by the Association through its Initiative and Networking Fund to 86 since 2005. The Helmholtz Enterprise funding programme supports spin-offs during the critical start-up phase, helping research findings to be applied rapidly for the benefit of society and the economy.

Press release

Print Version


    • N. N.
    • Head of Department Transfer and Innovation
      Helmholtz Association
    • Berlin Office
      Anna-Louisa-Karsch-Straße 2
      10178 Berlin


Leider gibt es keine Meldungen zu diesem Thema.